[1] DHILLON M, KHURANA A, PRABHAKAR S, et al. Crush Fractures of the Anterior end of Calcaneum. Indian J Orthop. 2018;52(3):244-252.
[2] CLARE MP, CRAWFORD WS. Managing Complications of Calcaneus Fractures. Foot Ankle Clin. 2017;22(1):105-116.
[3] 黄志锋,冼海庭,陈卫民.自体骨移植联合钛板内固定术对35例跟骨压缩性骨折患者足功能的影响[J].上海医药,2016,37(5):49-52.
[4] 晏波,厉泽众,代立武.小切口微创内固定治疗Sanders Ⅱ、Ⅲ型跟骨骨折49例[J].骨科,2018,9(4):327-329.
[5] 魏利成,余世明,刘丹平.解剖钢板内固定并植骨治疗跟骨骨折骨缺损的临床研究[J].中国骨与关节损伤杂志,2010,25(10):897-899.
[6] 李笛,汤健.不同植骨材料对跟骨骨折切口愈合的影响[J].实用骨科杂志,2013,19(10):894-896.
[7] 张俊杰,赵世波,王宇飞.锁定钢板联合同种异体骨/自体骨移植治疗Sanders Ⅲ、Ⅳ型跟骨骨折[J].骨科,2019,10(4):325-328.
[8] 张柏,祁琇,韩作峰,等.钛板联合植骨内固定修复跟骨骨折:外侧L形切口愈合的影响因素[J].中国组织工程研究,2016,20(26):3876-3882.
[9] 章芃,吴建华,汪畅,等.钢板内固定加同种异体骨植骨配合切口持续高负压引流治疗跟骨关节内骨折[J].临床骨科杂志,2017,20(3):365-367.
[10] 马延辉,王磊,董喆.跟骨板联合同种异体骨植骨治疗跟骨骨折效果分析[J].医学综述,2016,22(12):2486-2488.
[11] 荣向科,朱修文,刘刚义,等.急诊手术治疗跟骨关节内移位骨折的疗效观察[J].中国骨与关节损伤杂志,2019,34(12):1333-1335.
[12] 郑海峰,姜小利,刘健,等.同种异体骨植骨联合钢板内固定治疗SandersⅢ型跟骨骨折疗效观察[J].基层医学论坛,2020,24(10):1350-1352.
[13] 章明刚.两种植骨方式在SandersⅢ、Ⅳ型跟骨骨折术后疗效比较[J].浙江中西医结合杂志,2020,30(8):646-649+697.
[14] 王华,张晓明,林博文,等.硫酸钙人工骨材料应用于跟骨骨折12例[J].中国组织工程研究与临床康复,2010,14(34):6457-6460.
[15] 苏冠龙,王培吉,赵家举,等.锁定钢板加硫酸钙人工骨治疗跟骨关节内骨折[J].中国矫形外科杂志,2013,21(8):824-827.
[16] 王波,颜昌义,梁伦高,等.锁定钢板结合硫酸钙人工骨植骨治疗跟骨关节内骨折[J].齐齐哈尔医学院学报,2015,36(30):4596-4597.
[17] 罗亚平,汤峰,管志海.梭型自固化磷酸钙人工骨植骨结合锁定钢板内固定治疗跟骨关节内骨折[J].生物骨科材料与临床研究,2019,16(5):72-74.
[18] 周敏.新型可注射磷酸钙骨水泥联合空心螺钉内固定治疗sanderⅢ型跟骨骨折患者的临床效果[J].医疗装备,2017,30(23):159-160.
[19] 许文斌,徐义春,姚辉,等.自固化磷酸钙人工骨与异体骨治疗Sanders Ⅱ-Ⅳ型跟骨骨折的病例对照研究[J].中国骨伤,2018,31(7):594-598.
[20] 王大平,熊建义,朱伟民,等.纳米羟基磷灰石人工骨在骨缺损修复中的临床应用研究[J].中国临床解剖学杂志,2014,32(2):206-209.
[21] HIRAO M, EBINA K, ETANI Y, et al. Use of autologous bone grafting from the calcaneus and interconnected porous hydroxyapatite ceramic for bone transplantation in rheumatoid foot surgery. SAGE Open Med Case Rep.
2018; 6:2050313X18784413.
[22] GALLI MM, PROTZMAN NM, BLEAZEY ST, et al. Role of Demineralized Allograft Subchondral Bone in the Treatment of Shoulder Lesions of the Talus: Clinical Results With Two-Year Follow-Up. J Foot Ankle Surg. 2015; 54(4):717-722.
[23] LAREAU CR, HSU AR, ANDERSON RB. Return to Play in National Football League Players After Operative Jones Fracture Treatment. Foot Ankle Int. 2016;37(1):8-16.
[24] MITCHELL RJ, DUPLANTIER NL, DELGADO DA, et al. Plantar Plating for the Treatment of Proximal Fifth Metatarsal Fractures in Elite Athletes. Orthopedics. 2017;40(3):e563-e566.
[25] GANDHI A, VAN GELDEREN J, BERBERIAN W, et al. Platelet releasate enhances healing in patientswith a non-union. Transactions of the 49th Annual Meeting of the Orthopaedic Research Society, New Orleans, LA, 2003.
[26] BIBBO C, BONO CM, LIN SS. Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients. J Surg Orthop Adv. 2005;14(1):17-22.
[27] BIBBO C, PATEL DV, HASKELL MD. Recombinant bone morphogenetic protein-2 (rhBMP-2) in high-risk ankle and hindfoot fusions. Foot Ankle Int. 2009;30(7):597-603.
[28] KANAKARIS NK, MALLINA R, CALORI GM, et al. Use of bone morphogenetic proteins in arthrodesis: clinical results. Injury. 2009;40 Suppl 3:S62-S66.
[29] GIANAKOS A, NI A, ZAMBRANA L, et al. Bone Marrow Aspirate Concentrate in Animal Long Bone Healing: An Analysis of Basic Science Evidence. J Orthop Trauma. 2016;30(1):1-9.
[30] HERNIGOU P, POIGNARD A, BEAUJEAN F, et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005;87(7):1430-1437.
[31] ADAMS SB, LEWIS JS JR, GUPTA AK, et al. Cannulated screw delivery of bone marrow aspirate concentrate to a stress fracture nonunion: technique tip. Foot Ankle Int. 2013;34(5):740-744.
[32] HERNIGOU P, GUISSOU I, HOMMA Y, et al. Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes. Int Orthop. 2015;39(8):1639-1643.
[33] BORDEI P. Locally applied platelet-derived growth factor accelerates fracture healing. J Bone Joint Surg Br. 2011;93(12):1653-1659.
[34] DIGIOVANNI CW, LIN SS, BAUMHAUER JF, et al. Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft. J Bone Joint Surg Am. 2013;95(13):1184-1192.
[35] MANABE T, MORI S, MASHIBA T, et al. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone. 2007;40(6):1475-1482.
[36] ZHANG W, ZHU J, MA T, et al. Comparison of the effects of once-weekly and once-daily rhPTH (1-34) injections on promoting fracture healing in rodents. J Orthop Res. 2018;36(4):1145-1152.
[37] ALMIROL EA, CHI LY, KHURANA B, et al. Short-term effects of teriparatide versus placebo on bone biomarkers, structure, and fracture healing in women with lower extremity stress fractures: a pilot study. J Clin Transl Endocrinol. 2016;5:7-14.
[38] HETTRICH CM, BEAMER BS, BEDI A, et al. The effect of rhPTH on the healing of tendon-to-bonein a rat model. J Orthop Res. 2012;30(5):769-774.
[39] 俞光荣.跟骨骨折的治疗策略[J].上海医学,2005(7):541-543.
[40] NAITO K, SUGIYAMA Y, OBATA H, et al. Screw Fixation and Autogenous Bone Graft for an Irreducible Distal Ulna Fracture Associated with Distal Radius Fracture. J Hand Surg Asian Pac Vol. 2017;22(2):236-239.
[41] MÜLLER SA, BARG A, VAVKEN P, et al. Autograft versus sterilized allograft for lateral calcaneal lengthening osteotomies: Comparison of 50 patients. Medicine (Baltimore). 2016;95(30):e4343.
[42] SINGH R, SINGH D, SINGH A. Radiation sterilization of tissue allografts: A review. World J Radiol. 2016;8(4):355-369.
[43] 高升,孙军战,俞军卫.自体植骨与人工异体植骨在手术治疗跟骨骨折中的应用比较[J].安徽医学,2016,37(1):60-62.
[44] WALSH WR, MORBERG P, YU Y, et al. Response of a calcium sulfate bone graft substitute in a confined cancellous defect. Clin Orthop Relat Res. 2003; (406):228-236.
[45] 孙辉,臧学慧,高立华,等.可吸收人工骨粉修复跟骨粉碎性骨折[J].中国组织工程研究,2014,18(39):6375-6380.
[46] WEE J, THEVENDRAN G. The role of orthobiologics in foot and ankle surgery: Allogenic bone grafts and bone graft substitutes. EFORT Open Rev. 2017;2(6):272-280.
[47] ZHU W, WANG D, XIONG J, et al. Study on clinical application of nano-hydroxyapatite bone in bone defect repair. Artif Cells Nanomed Biotechnol. 2015;43(6):361-365.
[48] BIBBO C, HATFIELD PS. Platelet-rich plasma concentrate to augment bone fusion. Foot Ankle Clin. 2010;15(4):641-649.
[49] GUZEL Y, KARALEZLI N, BILGE O, et al. The biomechanical and histological effects of platelet-rich plasma on fracture healing. Knee Surg Sports Traumatol Arthrosc. 2015;23(5):1378-1383.
[50] MALHOTRA R, KUMAR V, GARG B, et al. Role of autologous platelet-rich plasma in treatment of long-bone nonunions: a prospective study. Musculoskelet Surg. 2015;99(3):243-248.
[51] DURAMAZ A, URSAVAŞ HT, BILGILI MG, et al. Platelet-rich plasma versus exchange intramedullary nailing in treatment of long bone oligotrophic nonunions. Eur J Orthop Surg Traumatol. 2018;28(1):131-137.
[52] DABRA S, CHHINA K, SONI N, et al. Tissue engineering in periodontal regeneration: A brief review. Dent Res J (Isfahan). 2012;9(6):671-680.
[53] SHIELDS LB, RAQUE GH, GLASSMAN SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976). 2006;31(5):542-547.
[54] COTTOM JM, PLEMMONS BS. Bone Marrow Aspirate Concentrate and Its Uses in the Foot and Ankle. Clin Podiatr Med Surg. 2018;35(1):19-26.
[55] HERNIGOU P, GUISSOU I, HOMMA Y, et al. Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes. Int Orthop. 2015;39(8):1639-1643.
[56] HERNIGOU P, DUBORY A, HOMMA Y, et al. Single-stage treatment of infected tibial non-unions and osteomyelitis with bone marrow granulocytes precursors protecting bone graft. Int Orthop. 2018;42(10):2443-2450.
[57] HOLLINGER JO, HART CE, HIRSCH SN, et al. Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am. 2008;90(Suppl 1):48-54.
[58] CAO R, BRAKENHIELM E, RAWLIUK R, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med. 2003;9(5):604-613.
[59] DIGIOVANNI CW, LIN S, PINZUR M. Recombinant human PDGF-BB in foot and ankle fusion. Expert Rev Med Devices. 2012;9(2):111-122.
[60] NEVINS M, GIANNOBILE WV, MCGUIRE MK, et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol. 2005;76(12):2205-2215.
[61] TOKUNAGA T, IDE J, ARIMURA H, et al. Local application of gelatin hydrogel sheets impregnated with platelet-derived growth factor BB promotes tendon-to-bone healing after rotator cuff repair in rats. Arthroscopy. 2015;31(8):1482-1491.
[62] KARAPLIS AC, GOLTZMAN D. PTH and PTHrP effects on the skeleton. Rev Endocr Metab Disord.2000;1(4):331-341.
[63] UZAWA T, HORI M, EJIRI S, et al. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1–34) on rat bone. Bone. 1995;16(4):477-484.
[64] HOCK JM, GERA I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res. 1992;7(1):65-72.
[65] VAHLE JL, SATO M, LONG GG, et al. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol. 2002;30(3):312-321.
[66] JOLETTE J, WILKER CE, SMITH SY, et al. Defining a Noncarcinogenic Dose of Recombinant Human Parathyroid Hormone 1–84 in a 2-Year Study in Fischer 344 Rats. Toxicol Pathol. 2006;34(7):929-940.
[67] ANDREWS EB, GILSENAN AW, MIDKIFF K, et al. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. J Bone Miner Res. 2012;27(12):2429-2437. |